Phase I study of to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of azidothymidine and colistin alone and in combination for urinary tract infections.
Phase of Trial: Phase I
Latest Information Update: 25 Apr 2018
Price : $35 *
At a glance
- Drugs Colistin (Primary) ; Colistin/zidovudine (Primary) ; Zidovudine (Primary)
- Indications Urinary tract infections
- Focus Adverse reactions
- 25 Apr 2018 New trial record
- 24 Apr 2018 Results (n=27) presented at the 28th European Congress of Clinical Microbiology and Infectious Diseases.
- 19 Apr 2018 According to the Helperby Therapeutics media release, data from this study presented at the European Congress of Clinical Microbiology and Infectious Diseases